Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT06340334
Eligibility Criteria:
Inclusion Criteria:
1. Age 18-65 years old;
2. Patients who have had a positive 13C or 14C breath test and have not received Helicobacter pylori eradication therapy before, or who have failed to eradicate in the early stage but have not received eradication therapy within half a year;
3. Voluntarily join this trial and sign the informed consent form.
Exclusion Criteria:
1. Allergy to the study drug (penicillin, amoxicillin, furazolidone, Tegoprazan, etc.);
2. Patients with active peptic ulcer disease;
3. Patients who have received Helicobacter pylori eradication therapy within half a year;
4. Use of antibiotics, bismuth, histamine H2 receptor antagonists or PPIs for 4 weeks before starting study treatment;
5. use of adrenocorticosteroids, non-steroidal anti-inflammatory drugs or anticoagulants;
6. History of esophageal or gastric surgery;
7. Pregnant or lactating women;
8. Suffering from serious concomitant diseases, such as liver disease, cardiovascular disease, lung disease, kidney disease;
9. Alcoholism.
10. Gastric mucosa-associated lymphoid tissue lymphoma (MALT), malignant tumor diseases.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06340334
Study Brief:
Protocol Section:
NCT06340334